Lemme has entered the longevity supplements category with Lemme NAD+, a daily capsule that combines clinically studied nicotinamide mononucleotide (NMN) with ingredients targeting cellular health and skin appearance.
The formula is built around NMN, a precursor that the body uses to produce NAD+, a coenzyme involved in essential cellular processes.
Research has indicated that NAD+ levels can decline with age, which in turn has created growing interest in nutritional strategies designed to support NAD+ metabolism as part of healthy ageing and longevity.
Dr Kathleen Valenton, Chief Medical Officer at Lemme, said this interest reflects a shift towards more proactive approaches to healthy ageing, with consumers looking to understand what they can do to support how they feel and function with time.
She added that the longevity category is becoming more sophisticated as consumers seek products grounded in credible science while remaining relevant to everyday life.
A multidimensional approach to healthy ageing
But, rather than supplementing NAD+ directly, Lemme has instead selected NMN as the core ingredient.
Dr Valenton said that NAD+ itself can break down before reaching cells, while NMN is converted by the body into NAD+.
“NMN is the direct precursor your body converts into NAD+,” she said, adding that it sits one enzymatic step closer to NAD+ than other precursors.
The choice of formulation also reflects the growing convergence between longevity and beauty-from-within supplements.
Lemme NAD+ contains
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.
